Pembrolizumab Monotherapy in Relapsed Hepatocellular Carcinoma Post Living Donor Liver Transplantation and Sorafenib

Nasr F., Al Ghoche A., Diab S., Maddah J., Mansour L., Kassem A.,Gheith A.K. Published online 2018 November 12, Abstract Background Despite of the high incidence of hepatocellular carcinoma (HCC), treatment strategies stays restrained. New treatment aspects remain a necessity to improve overall survival of patients. Case report Here, we report for the first time

Read more